Annual Net Margin
31.07%
+0.93%+3.09%
December 31, 2024
Summary
- As of February 20, 2025, REGN annual net profit margin is 31.07%, with the most recent change of +0.93% (+3.09%) on December 31, 2024.
- During the last 3 years, REGN annual net margin has fallen by -19.18% (-38.17%).
- REGN annual net margin is now -42.92% below its all-time high of 54.43%, reached on December 31, 2012.
Performance
REGN Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
24.22%
-11.81%-32.78%
December 31, 2024
Summary
- As of February 20, 2025, REGN quarterly net profit margin is 24.22%, with the most recent change of -11.81% (-32.78%) on December 31, 2024.
- Over the past year, REGN quarterly net margin has dropped by -9.55% (-28.28%).
- REGN quarterly net margin is now -59.84% below its all-time high of 60.31%, reached on June 30, 2021.
Performance
REGN Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
REGN Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.1% | -28.3% |
| 3 y3 years | -38.2% | -28.3% |
| 5 y5 years | -3.7% | -28.3% |
REGN Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.2% | +3.1% | -46.2% | +5.5% |
| 5 y | 5-year | -38.2% | +3.1% | -59.8% | +5.5% |
| alltime | all time | -42.9% | +105.5% | -59.8% | +103.3% |
Regeneron Pharmaceuticals Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | 31.07%(+3.1%) | 24.22%(-32.8%) |
| Sep 2024 | - | 36.03%(-10.8%) |
| Jun 2024 | - | 40.38%(+75.9%) |
| Mar 2024 | - | 22.96%(-32.0%) |
| Dec 2023 | 30.14%(-15.4%) | 33.77%(+12.7%) |
| Sep 2023 | - | 29.97%(-2.3%) |
| Jun 2023 | - | 30.66%(+18.6%) |
| Mar 2023 | - | 25.86%(-26.2%) |
| Dec 2022 | 35.64%(-29.1%) | 35.06%(-21.8%) |
| Sep 2022 | - | 44.81%(+50.3%) |
| Jun 2022 | - | 29.82%(-9.2%) |
| Mar 2022 | - | 32.83%(-27.1%) |
| Dec 2021 | 50.25%(+21.5%) | 45.01%(-4.8%) |
| Sep 2021 | - | 47.27%(-21.6%) |
| Jun 2021 | - | 60.31%(+36.8%) |
| Mar 2021 | - | 44.10%(-7.0%) |
| Dec 2020 | 41.35%(+28.2%) | 47.43%(+29.2%) |
| Sep 2020 | - | 36.71%(-20.1%) |
| Jun 2020 | - | 45.97%(+34.6%) |
| Mar 2020 | - | 34.16%(-19.6%) |
| Dec 2019 | 32.26%(-32.1%) | 42.50%(+10.7%) |
| Sep 2019 | - | 38.40%(+213.7%) |
| Jun 2019 | - | 12.24%(-63.6%) |
| Mar 2019 | - | 33.59%(-6.0%) |
| Dec 2018 | 47.50%(+132.7%) | - |
| Sep 2018 | - | 35.75%(+4.3%) |
| Jun 2018 | - | 34.29%(+8.4%) |
| Mar 2018 | - | 31.62%(+188.5%) |
| Dec 2017 | 20.41%(+10.8%) | 10.96%(-57.7%) |
| Sep 2017 | - | 25.88%(-1.9%) |
| Jun 2017 | - | 26.38%(+39.8%) |
| Mar 2017 | - | 18.87%(-8.5%) |
| Dec 2016 | 18.42%(+18.8%) | 20.63%(-4.9%) |
| Sep 2016 | - | 21.70%(+34.1%) |
| Jun 2016 | - | 16.18%(+7.2%) |
| Mar 2016 | - | 15.10%(+6.9%) |
| Dec 2015 | 15.50%(+29.3%) | 14.12%(-23.7%) |
| Sep 2015 | - | 18.50%(-5.1%) |
| Jun 2015 | - | 19.49%(+123.0%) |
| Mar 2015 | - | 8.74%(-22.2%) |
| Dec 2014 | 11.99%(-39.0%) | 11.23%(-2.3%) |
| Sep 2014 | - | 11.49%(-20.6%) |
| Jun 2014 | - | 14.47%(+32.5%) |
| Mar 2014 | - | 10.92%(-22.7%) |
| Dec 2013 | 19.66%(-63.9%) | 14.12%(-40.3%) |
| Sep 2013 | - | 23.67%(+24.0%) |
| Jun 2013 | - | 19.09%(-15.1%) |
| Mar 2013 | - | 22.49%(-49.8%) |
| Dec 2012 | 54.43%(-209.4%) | - |
| Sep 2012 | - | 44.77%(+77.6%) |
| Jun 2012 | - | 25.21%(+401.2%) |
| Mar 2012 | - | 5.03%(-111.6%) |
| Dec 2011 | -49.74%(+118.5%) | -43.46%(-28.3%) |
| Sep 2011 | - | -60.65%(+4.6%) |
| Jun 2011 | - | -57.98%(+49.7%) |
| Mar 2011 | - | -38.72%(+254.6%) |
| Dec 2010 | -22.76%(+27.3%) | -10.92%(-65.8%) |
| Sep 2010 | - | -31.96%(+45.4%) |
| Jun 2010 | - | -21.98%(-25.4%) |
| Mar 2010 | - | -29.48%(-21.8%) |
| Dec 2009 | -17.88%(-46.1%) | -37.70%(+4283.7%) |
| Sep 2009 | - | -0.86%(-94.8%) |
| Jun 2009 | - | -16.59%(-19.2%) |
| Mar 2009 | - | -20.52%(-59.0%) |
| Dec 2008 | -33.18%(-60.7%) | -50.03%(+55.4%) |
| Sep 2008 | - | -32.20%(+4.5%) |
| Jun 2008 | - | -30.81%(+49.5%) |
| Mar 2008 | - | -20.61%(+2.1%) |
| Dec 2007 | -84.46% | -20.19%(-87.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2007 | - | -160.63%(+33.2%) |
| Jun 2007 | - | -120.63%(-36.3%) |
| Mar 2007 | - | -189.49%(-36.7%) |
| Dec 2006 | -161.30%(+11.9%) | -299.35%(+70.6%) |
| Sep 2006 | - | -175.44%(+43.3%) |
| Jun 2006 | - | -122.42%(+9.4%) |
| Mar 2006 | - | -111.86%(-34.3%) |
| Dec 2005 | -144.19%(-701.8%) | -170.29%(-20.4%) |
| Sep 2005 | - | -213.98%(+29.7%) |
| Jun 2005 | - | -164.97%(+548.5%) |
| Mar 2005 | - | -25.44%(-529.0%) |
| Dec 2004 | 23.96%(-112.8%) | 5.93%(-119.6%) |
| Sep 2004 | - | -30.33%(-40.8%) |
| Jun 2004 | - | -51.20%(-43.8%) |
| Dec 2003 | -186.89%(-67.0%) | -91.09%(-42.2%) |
| Sep 2003 | - | -157.54%(-53.8%) |
| Jun 2003 | - | -340.82%(+14.7%) |
| Mar 2003 | - | -297.06%(-59.1%) |
| Dec 2002 | -565.66%(+63.2%) | -726.65%(+45.4%) |
| Sep 2002 | - | -499.79%(-8.5%) |
| Jun 2002 | - | -546.29%(+6.1%) |
| Mar 2002 | - | -514.98%(-20.1%) |
| Dec 2001 | -346.70%(+785.3%) | -644.81%(+77.3%) |
| Sep 2001 | - | -363.70%(+41.7%) |
| Jun 2001 | - | -256.69%(+24.3%) |
| Mar 2001 | - | -206.51%(+367.4%) |
| Dec 2000 | -39.16%(-41.5%) | -44.18%(+112.5%) |
| Sep 2000 | - | -20.79%(+6.0%) |
| Jun 2000 | - | -19.62%(-71.9%) |
| Mar 2000 | - | -69.71%(+492.8%) |
| Dec 1999 | -66.96%(+198.3%) | -11.76%(-72.9%) |
| Sep 1999 | - | -43.36%(-67.2%) |
| Jun 1999 | - | -132.20%(-19.8%) |
| Mar 1999 | - | -164.81%(+127.7%) |
| Dec 1998 | -22.45%(-47.9%) | -72.37%(+458.4%) |
| Sep 1998 | - | -12.96%(-183.3%) |
| Jun 1998 | - | 15.56%(-126.6%) |
| Mar 1998 | - | -58.46%(-707.7%) |
| Dec 1997 | -43.12%(-67.9%) | 9.62%(-145.1%) |
| Sep 1997 | - | -21.35%(-67.2%) |
| Jun 1997 | - | -65.15%(-31.5%) |
| Mar 1997 | - | -95.16%(-23.6%) |
| Dec 1996 | -134.44%(+56.7%) | -124.62%(-13.2%) |
| Sep 1996 | - | -143.55%(+17.1%) |
| Jun 1996 | - | -122.58%(-18.3%) |
| Mar 1996 | - | -150.00%(+11.5%) |
| Dec 1995 | -85.77%(-35.2%) | -134.48%(+17.4%) |
| Sep 1995 | - | -114.52%(+97.8%) |
| Jun 1995 | - | -57.89%(-4.9%) |
| Mar 1995 | - | -60.87%(-19.2%) |
| Dec 1994 | -132.33%(-64.8%) | -75.32%(+67.6%) |
| Sep 1994 | - | -44.94%(-84.1%) |
| Jun 1994 | - | -283.33%(-20.6%) |
| Mar 1994 | - | -356.67%(-10.1%) |
| Dec 1993 | -376.42%(+126.6%) | -396.55%(+48.7%) |
| Sep 1993 | - | -266.67%(-63.1%) |
| Jun 1993 | - | -723.08%(+63.3%) |
| Mar 1993 | - | -442.86%(+59.2%) |
| Dec 1992 | -166.09%(+169.5%) | -278.26%(+15.1%) |
| Sep 1992 | - | -241.67%(+109.0%) |
| Jun 1992 | - | -115.63%(+22.6%) |
| Mar 1992 | - | -94.29%(-10.2%) |
| Dec 1991 | -61.64%(-6.6%) | -105.00%(+121.7%) |
| Sep 1991 | - | -47.37%(+168.4%) |
| Jun 1991 | - | -17.65%(-67.9%) |
| Mar 1991 | - | -55.00%(-20.6%) |
| Dec 1990 | -66.00% | -69.23%(+12.5%) |
| Sep 1990 | - | -61.54%(-7.7%) |
| Jun 1990 | - | -66.67%(0.0%) |
| Mar 1990 | - | -66.67% |
FAQ
- What is Regeneron Pharmaceuticals annual net profit margin?
- What is the all time high annual net margin for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual net margin year-on-year change?
- What is Regeneron Pharmaceuticals quarterly net profit margin?
- What is the all time high quarterly net margin for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly net margin year-on-year change?
What is Regeneron Pharmaceuticals annual net profit margin?
The current annual net margin of REGN is 31.07%
What is the all time high annual net margin for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual net profit margin is 54.43%
What is Regeneron Pharmaceuticals annual net margin year-on-year change?
Over the past year, REGN annual net profit margin has changed by +0.93% (+3.09%)
What is Regeneron Pharmaceuticals quarterly net profit margin?
The current quarterly net margin of REGN is 24.22%
What is the all time high quarterly net margin for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly net profit margin is 60.31%
What is Regeneron Pharmaceuticals quarterly net margin year-on-year change?
Over the past year, REGN quarterly net profit margin has changed by -9.55% (-28.28%)